Transcript with Q&As in Acrobat PDF format (315 KB)
Investor Presentation PowerPoint slides (552 KB)
Investor Presentation Appendix PowerPoint slides (689 KB)
Transcript with Q&As in Acrobat PDF format (500 KB)
Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 32,500 employees in 74 countries, and markets its products in 179 countries.
 | Novo Nordisk in the USA |
 | Novo Nordisk in Denmark |
Or choose:
